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Abstract
There is a growing recognition that needs more to be done to ensure that research contributes to
better health services and patient outcomes. Stakeholder engagement in research, including co-
production, has been identified as a promising mechanism for improving the value, relevance
and utilization of research. This article presents findings from a prospective study which explored
the impact of stakeholder engagement in a 3-year European tobacco control research project.
That research project aimed to engage stakeholders in the development, testing and dissemin-
ation of a return-on-investment tool across five EU countries (the Netherlands, Spain, Hungary,
Germany and the UK). The prospective study comprised interviews, observations and document
review. The analysis focused on the extent to which the project team recognized, conceptualized
and operationalized stakeholder engagement over the course of the research project. Stakeholder
engagement in the European research project was conceptualized as a key feature of pre-desig-
nated spaces within their work programme. Over the course of the project, however, the tool de-
velopment work and stakeholder engagement activities decoupled. While the modelling and tool
development became more secluded, stakeholder engagement activities subtly transformed from
co-production, to consultation, to something more recognizable as research participation. The
contribution of this article is not to argue against the potential contribution of stakeholder engage-
ment and co-production, but to show how even well-planned engagement activities can be
diverted within the existing research funding and research production systems where non-
research stakeholders remain at the margins and can even be seen as a threat to academic
identify and autonomy.
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1. Introduction
There is a growing recognition that needs more to be done to ensure
that health research is fully mobilized to support improvements in
health services and ultimately in outcomes for patients (Oliver et al.
2019). However, in seeking to understand the problem and potential
solutions, much of the literature has focused on shortcomings of po-
tential evidence users (such as health care practitioners) and their
organizations (Ferlie et al. 2000; Currie and Suhomlinova 2006).
This has most commonly been conceptualized as a limited absorp-
tive capacity to use research in health care organizations (Zahra and
George 2002). Less attention has been placed on the roles and
behaviours of academics and their organizations in supporting or
inhibiting the use of research. It might be assumed that, as know-
ledge producers, research organizations will play a full and active
role in supporting the use of research. But, as others have shown, re-
search organizations may have conflicting interests that can obstruct
research utilization efforts (Kogan and Henkel 1983; Rip 2001).
However, there is a drive for academic researchers to build links
with individuals and organizations outside of the academy. In the
UK, the influential review by Sir Paul Nurse advocated a more dy-
namic relationship between organizations that produce and those
that use healthcare research (Nurse 2015). This forms part of a
wider shift towards more networked and collaborative forms of
working for public sector organizations (Kislov 2018) and an appre-
ciation of interdisciplinary and team-based science (Roelofs et al.
2019). The importance of engagement as critical to processes of
change can also be seen as part of a longer tradition within social
science research (Lewin 1958; Habermas 1987). This tradition has
been described by Glerup and Horst (2014) as an integration ration-
ality which conceptualizes knowledge production as a fundamental-
ly collaborative process.
Much of this work on supporting the use of research evidence
focuses on improving relationships between different actors in the
evidence system (Zimmerman 2020). This is often defined as linking
with those with a ‘stake’ in the research, or ‘stakeholders’ (Boaz
et al. 2018). Who these stakeholders differs—ranging from patients,
to policymakers, or more generally potential research users.
Stakeholder engagement is considered to have a number of potential
benefits including improving research questions, research tools and
practices, supporting dissemination and building longer term re-
search-practice partnerships. There is also some evidence to suggest
that stakeholder engagement might be a potential mechanism for
improving research impact in terms of both healthcare practices and
outcomes for patients (Kok et al. 2016; Boaz et al. 2018).
The literature often refers to a spectrum of approaches to en-
gagement, suggesting that stakeholders can be engaged in diverse
ways that range from providing them with information, to consult-
ation or co-producing research with them (Boaz and Metz 2020).
The debate has shifted further, with increased emphasis on the po-
tential contribution and challenges involved in co-producing health
services research (Filipe et al. 2017). In particular, there has been a
debate about what has been described as the ‘dark side’ of co-pro-
duction (Oliver et al. 2019; Williams et al. 2020). While the terms
co-creation and co-production are now widely used, it is less clear to
what extent they signal a change in attitudes and practices (Locock
and Boaz 2019).
There are a range of programmes in place to support stakeholder
engagement in research. For example, in the USA there has been a
widespread adoption of research practice partnerships (Coburn and
Penuel 2016) and the development of the US Patient-Centered
Outcomes Research Institute’s (PCORI) database of articles on
stakeholder engagement in research, while in Canada knowledge
translation activities have been developed to connect researchers
with policy stakeholder communities (Gagliardi et al. 2015). The
drive to promote links with stakeholders is captured in most know-
ledge transfer models. In particular, stakeholder engagement aligns
with what Best and Holmes (2010) describe as relational models of
knowledge transfer. These models represent a shift from preoccupa-
tions with conventional dissemination activities, adding a focus on
interactions between people using and producing research, including
the development of partnerships and the establishment of networks
(Best and Holmes 2010). Capturing these interactions has proved
challenging for the field of research evaluation for some time
(Molas-Gallart and Tang 2011).
There are few empirical studies of stakeholder engagement, par-
ticularly taking a prospective approach. In 2013, the UK Medical
Research Council (MRC) funded a prospective study of stakeholder
engagement in an EU-funded tobacco control research programme
(EQUIPT). The EQUIPT programme was funded to adapt, scale and
spread a return-on-investment tool to support decision making in to-
bacco control policy in five European countries. The original tool
had been developed in the UK with funding from the National
Institute for Clinical Excellence and significant investment from a
range of specific stakeholders, including commissioners, service pro-
viders, public health directors, local authorities, Smokefree Regional
Offices and academics (Pokhrel et al. 2014a). The EQUIPT pro-
gramme had an explicit theory of change that underlined the import-
ance of engaging stakeholders to develop the tool and promote its
impact. The MRC study (SEE Impact) provided an opportunity for
using ethnographic methods to study how stakeholders were
engaged during the course of the EQUIPT research programme and
to compare differences between stakeholder engagement in the dif-
ferent countries.
In this article, we address the following question: what can we
learn from prospectively studying how academics recognize, concep-
tualize and operationalize stakeholder engagement over the course
of a European research project?
2. Methods
This article presents findings from a prospective study which
explored the impact of stakeholder engagement in a 3-year tobacco
control research project. Drawing on literature from science and
technology studies that explore the role of stakeholders in research
(Jasanoff 2004; Callon et al. 2009) and Henkel’s work on academic
identity (Henkel 2005), the article focuses in particular on the extent
to which the EQUIPT project team recognized, conceptualize and
operationalize stakeholder engagement over the course of the study.
The EQUIPT research project aimed to engage stakeholders in the
development, testing and dissemination of a tobacco control return-
on-investment tool across five EU countries (i.e. Netherlands, Spain,
Hungary, Germany and the UK). Data collection of this study com-
prised interviews with the project team and stakeholders of the
EQUIPT research project, observations of meetings and events
involving these stakeholders and a review of documents relevant to
the meetings and events. Our study design repeatedly adapted to the
organization of the EQUIPT project to be able to study and reflect
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on changes in the engagement plans and project activities of the
EQUIPT team.
2.1 Interviews
Fifty interviews were conducted with stakeholders (n ¼ 45) and
with members of the project research team (n ¼ 5). The stakeholder
interviews comprised six in Germany, eight in Hungary, thirteen in
the Netherlands, nine in Spain and nine in the UK. Interviews took
place between April 2015 and September 2016. In Germany,
Hungary, the Netherlands and Spain, interviews were conducted
face-to-face. In the UK, eight interviews were conducted over the
telephone and one was face-to-face. Interviews were digitally
recorded, translated into English where relevant, and transcribed.
Questions were open-ended and investigated the circumstances
around stakeholders’ awareness of and involvement in EQUIPT,
expectations of involvement in the project, the type and level of
interaction with the EQUIPT team, benefits gained through working
with EQUIPT, the perceived influence of stakeholder engagement on
the project, and barriers to effective engagement.
2.2 Observations
Six stakeholder events were observed comprising: four events for
EQUIPT team members and key stakeholders who formed the proj-
ect’s Research Advisory Group and two events aimed at dissemin-
ation beyond key stakeholders. The number of stakeholders who
took part in the six events ranged between 22 and 60. The initial
objectives of the EQUIPT project for engaging stakeholders in events
were to gain feedback on the use of the ROI tool; gain support for
the validation of the ROI tool; and discuss and disseminate findings
about the development of the ROI tool. Each of the six stakeholder
events was observed by two or three SEE-Impact researchers. The
events were held in Maastricht, Brussels (two events), Budapest,
London and Zagreb. The first event in Maastricht in February 2014
was a 3-day EQUIPT project team meeting. The second event in
Brussels in October 2014 was the EQUIPT project’s first annual
team meeting and lasted 2 days. The third event in Budapest in
September 2015 was the project’s second annual meeting and also
lasted 2 days. The fourth event in London in March 2016 was a half
day workshop for stakeholders to give feedback to the EQUIPT
team on an earlier, similar UK ROI tool which had been in use in
the UK for some time. The fifth event took place in Zagreb in June
2016 and was a 1-day international workshop for potential stake-
holders from other European countries beyond the five sample
countries with the aim of supporting validation of the ROI tool in
lower-income European countries. The final 3-day event in Brussels
in October 2016 presented the findings of the study. In addition, six
EQUIPT team meetings were observed in order to gain insight into
the team’s views and attitudes towards stakeholder engagement, and
to learn promptly of any amendments to plans for stakeholder en-
gagement. EQUIPT team meetings were held monthly and took
place via teleconference because of the spread of team members
across the five sample countries and Croatia as co-ordinator for out
of sample countries. Meetings lasted approximately 1.5 h. Detailed
field notes were taken at EQUIPT programme events, usually by at
least two members of the research team.
2.3 Analysis
The three interviewers involved prepared detailed summaries after
each semi-structured interview. These summaries covered both the
content and setting of the interviews and provided ‘thick descrip-
tions’ (Geertz 1973) of how stakeholders were engaged in EQUIPT.
The research team used these descriptions to arrive at a first over-
view of recurring or deviating themes in the data. The interview
transcripts and observations were organized in NVivo (QSR
International 2020) and an abductive analysis approach was used to
provide the data with codes. This abductive approach combines a
theory-informed approach to data analysis with empirical insights
from the data (Stoopendaal and Bal 2013; Tavory and Timmermans
2014). In practice, this involved a first round of inductive coding,
followed by a second round where these codes were compared to
existing theory and codes were added or changed. An example is
how we inductively developed our code ‘stakeholder engagement’.
In our data, this code increasingly reflected activities that could also
be seen as data collection for academic purposes. The literature on
stakeholder engagement that we used, and the earlier UK experience
developing the original tool, however, mainly referred to stakehold-
er engagement as a way to create ownership and legitimacy. By com-
paring the meaning of the code in our data with how it is used in our
conceptual literature, we observed a contradiction that we could fur-
ther explore in our analysis.
3. Findings
The presentation of the findings of this study will start with an over-
view of how the EQUIPT team planned stakeholder engagement,
and what their rationale for doing such engagement was.
Subsequently, findings are presented sequentially focussing around
the four main programme events and combining data from event
observations, project documents and interviews with the project
team and key stakeholders.
3.1 Stakeholder engagement planning and rationale
The aim of EQUIPT was to develop country-specific tools to support
decision makers (including local policy makers and those procuring
public health interventions) in accessing predictions of likely returns
on investment arising from funding different tobacco control inter-
ventions (Pokhrel et al. 2014b). EQUIPT set out with a clear work
plan to engage with stakeholders from the beginning and throughout
the programme. A wide range of terms were used by the team to de-
scribe work with potential stakeholders’ including stakeholder en-
gagement, co-creation and co-production. The study protocol used
the language of ‘co-creation’ to signal their intent to work closely
with stakeholders on the adaption, scale and spread of the return-
on-investment tool to other European countries (Pokhrel et al.
2014b). Within the study design, there were two elements with an
explicit focus on stakeholder engagement: in the so-called ‘working
space’ where the return-on-investment tool was to be developed
(where a process of co-creation with stakeholders was envisaged)
and in the so-called ‘transfer space’ where stakeholder engagement
was considered to be integral to the process of disseminating the re-
turn-on-investment tool. The EQUIPT funding agreement part B
document states that the following stakeholder groups would be tar-
geted: ‘(1) National and European stakeholders consisting of policy-
makers, academics, health authorities, insurance companies,
advocacy groups, ministry of finance, national committees, clini-
cians and health technology assessment (HTA) professionals—the
outcomes of engagement with Target Group 1 will be used to obtain
an optimum assessment of preconditions for usability of the final
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ROI tool (Task 4); and (2) Experts on smoking cessation and
HTA—the outcomes of engagement with Target Group 2 will be
used to obtain an optimum assessment of the parameters to be
included in the final ROI tool, taking into account the variability of
smoking cessation/prevention methods used between different coun-
tries.’ (EQUIPT Description of Work Part B)
A work package, with a detailed programme of engagement
activities, was dedicated to working with stakeholders. There were
also stakeholder engagement activities planned within other work
packages to support tool development and dissemination. In total,
the proposed stakeholder engagement activity detailed in the de-
scription of work for the study consisted of: a stakeholder survey
across five countries (EQUIPT Description of Work Part A, p3 of
23, last para), 10 consensus workshops within each country and two
further consensus workshops across all countries (EQUIPT
Description of Work Part A, p4 of 23, last para.). Piloting of the
country-specific ROI tools involving all stakeholders engaged in pre-
vious activities (EQUIPT Description of Work Part A, p7 of 23, last
3 paras); Consultation with local researchers and policy makers in
the out of sample Central and Eastern European countries regarding
collection of local data. (EQUIPT Description of Work Part A, p10
of 23, 3rd para); a workshop of UK regional and national stakehold-
ers (EQUIPT Description of Work Part A, p12 of 23, 2nd para.); an
international workshop of stakeholders in non-sample Central &
Eastern Europe countries, (EQUIPT Description of Work Part A,
p3 of 23, 4th para); A project website needs-assessment conducted
via an online survey organized by country leads. (EQUIPT
Description of Work Part A, p14 of 23, 1st para); Invitations to
stakeholders to attend selected project meetings as appropriate
(EQUIPT Description of Work Part A, p15 of 23, 3rd para);
Network Building by collaborating with key networks and health
organizations. (EQUIPT Description of Work Part A, p15 of 23,
4th para).
This commitment to stakeholder engagement had roots in the
prior work of a number of the co-investigators who had had a posi-
tive experience of stakeholder engagement as part of the develop-
ment of a previous project. The funder of the original return on
investment tool study in the UK supported a high level of stakehold-
er engagement in the work that it funded (Pokhrel et al. 2014a). At
the final event, one of the EQUIPT team who had been engaged in
the prior work in the UK and had a policy role, reflected on the po-
tential for stakeholder engagement to build long term relationships,
support and potential for use:
‘It is about a way of working, participation and coalition build-
ing around a piece of work that creates that acceptability, that
willingness to create usability that had been so important in the
previous work. . .Those who have been engaged are much more
likely to use. Jack Smith [An attendee at the final event] was one
of the original stakeholders in the [UK] ROI project and is now
still engaging with us from a policy level perspective’ Angela, UK
regional smoking policymaker
Jack had been engaged as a policy stakeholder in the develop-
ment of the previous ROI tool. His role as a stakeholder had
changed over time, but his relationship with the team and his inter-
est in and understanding of the ROI product meant that now, in a
more senior and influential role, he could be a powerful ally in sup-
porting the use of the new EQUIPT tool in UK smoking cessation
policy. This understanding of the dual roles of stakeholder engage-
ment in improving the quality of the tool and supporting potential
future use seemed to be shared throughout the team and at different
levels of seniority from the outset. One of the more junior research-
ers articulated it as follows:
‘The idea is that we should involve stakeholders at an early stage
anyway, probably because they then feel that they can also pro-
vide input in the development of the tool and that ultimately
leads to more easy behavioural change. Um and that the tool is
better adapted for them.’ Peter, EQUIPT researcher
This view was echoed by more senior colleagues:
‘So basically everything is used for, everything is, everything has
the idea that, by involving stakeholders, you can make the model
more tailored to their wishes and their ideas, making it better
and more used, so to speak.’ Ana, Theme Lead, EQUIPT
This quotation demonstrates the different theoretical frame-
works individual members of the EQUIPT team were drawing on. In
this case, individual behaviour change models were dominant in the
thinking about stakeholder engagement of both the individual re-
searcher and his colleagues in the work package, several of whom
were psychologists by background.
3.2 How stakeholder engagement in the project
evolved
3.2.1 Maastricht—February, 2014
At the first annual project meeting, the work package leading on
stakeholder engagement presented a strategy for categorizing key
stakeholders into five groups. These groups were: (1) decision mak-
ers, (2) purchasers of services or pharmaceutical products, (3) pro-
fessionals service deliverers, (4) evidence generators (e.g.
researchers) whose work informs policy, procurement, or delivery of
services and (5) advocates of health promotion. In addition, the
work package presented a shared methodology for initial engage-
ment with stakeholders through face-to-face interviews. There was a
very positive reaction from across the team to work done to concep-
tualize stakeholders into different groups and to develop a detailed
interview questionnaire to gather stakeholder views at the outset of
the study. Some of the team voiced concern over whether it would
be possible to engage with every stakeholder category across the dif-
ferent countries. They argued that some groups would be less preva-
lent, or generally less inclined to participate in scientific projects.
The Maastricht meeting was also intended to explain and pilot
the stakeholder questionnaire among the EQUIPT team members. A
junior researcher, who was hired to co-develop the questionnaire
and coordinate the first work package, would later explain the ob-
jective of using the questionnaire as follows:
“. . . the purpose of the questionnaire is to improve the tool, so
that we are provided with input on how we can develop the tool
in such a way that it aligns as much as possible with the stake-
holders. So, we look at what evidence types they are interested
in, but also perhaps which usability, um, characteristics they find
necessary. But I really combined this with scientific research that
we find interesting, namely we have integrated that with the I-
Change model. . . So, we have the objective for EQUIPT and an
objective to conduct our own research and we integrated that in
a questionnaire. Um, there is overlap, But then you can under-
stand better why we used a questionnaire in the interview, be-
cause we, because they, because the stakeholders can score on all
items of the I-Change model. So that we can do research and can
look at what we can improve about the tool. So, they were not






/rev/advance-article/doi/10.1093/reseval/rvab013/6272492 by guest on 14 M
ay 2021
really real interviews, it was more really very, it were very struc-
tured interviews in which they really just had to fill out a ques-
tionnaire.” Peter, EQUIPT researcher
The questionnaire itself was composed of 19 structured ques-
tions, mostly requiring Likert-type answers and including several
sub-questions. The information sheet of the questionnaire explained
that the interview ‘(. . .) should last approximately 40 min’ and—
with the respondent’s verbal agreement—would be audio recorded
‘to save time’. Most of the survey interviews with EQUIPT stake-
holders were conducted between January and July 2014. Shortly
after, the SEE-Impact team approached several of these stakeholders
for a semi-structured interview on their experiences being engaged
with EQUIPT. Most stakeholders explained that they could not re-
call the exact content of the interview, nor whether they were satis-
fied with it. Stakeholders like Matthew expressed some confusion
about what and how they were being engaged in the EQUIPT study:
Matthew [EQUIPT stakeholder]: I believe that he had a, a, uh,
list with questions that he followed quite strictly, I think. And he
had, yes, he had a computer with him, on which he showed
things. A laptop or something.
Interviewer: Yes, he probably showed a video?
Matthew [EQUIPT stakeholder]: Yes! Yes! And that was sur-
rounded by some sort of standardised story, by him, and that is
what he then did entirely: telling that standard story. And, and,
uh, asking questions before, yes. Watching something, asking
questions afterwards and then at the end there was this sort of
standard question, like: do you have other comments? That is
when I mentioned several things. Things that, for me I think,
were most important. And I have no notion whatsoever as to
what happened with those things.
At this point, the idea that stakeholders would be beginning to see
themselves as partners in the research process with some ownership of
the tool seems to be slipping away, as Matthew describes an experience
of participating in more of a one-way data collection exercise.
3.2.2 Brussels—October 2014
By the second annual project meeting in Brussels, a number of chal-
lenges to stakeholder engagement were emerging. In particular, the
time required to gather feedback directly from stakeholders was
proving difficult to reconcile with the needs of the modellers (work-
ing on the new return on investment tool), the demands of the tech-
nical tool adaptation process and development process. This was
further compounded by the decision by the funder to require all
grant holders to adhere to their original timeline (with end dates
remaining set regardless of project delays) (Boaz et al. 2018).
The need to deliver the adaptation of the tool on time led to a
rethinking about the intensity and method for stakeholder engage-
ment. After much discussion, the large number of face-to-face meet-
ings planned with stakeholders were replaced by recorded SKYPE
calls with stakeholders focused on testing the adapted tool. In add-
ition, the planned ‘consensus workshop’ was reframed into a usabil-
ity test of the model. Initially, the workshop aimed at arriving at
consensus among stakeholders regarding the most important smok-
ing-related diseases to include in the model. At this stage, however,
the modellers seemed concerned that this step would further lag the
already delayed development of the tool.
‘At the end of the first project day, it seems that the modellers are
constantly asked to change their variables and input data.
Although they articulate their concerns quite modestly, their
faces express unease. Discussion is constantly focussed on what
is in or outside the model’ exert from SEE-Impact researcher field
notes
One of the senior researchers in the project suggested to focus on
usability of the model instead. Using terms as ‘back-up plans’ and
‘thinking out of the box’, he hinted at a digital approach where
stakeholders could use the model whilst researchers could gather
data about the usability of the model—thus noting a shift towards a
more dissemination focussed engagement strategy.
3.2.3 Budapest—September 2015
By the third annual meeting in Budapest, a further shift had occurred
which seemed less driven by the technical elements of tool develop-
ment and the requirements of the modellers. At this stage, the
EQUIPT research team seemed to be describing a pull towards gen-
erating knowledge suitable for publication. The researchers reported
on a decision to conduct a survey of stakeholders to gather feedback
on the tool. This validation exercise was conducted in a more con-
ventionally scientific format. While the researchers discussed the
results in terms of their utility for tool development, they also
emphasized the potential for generating academic publications based
on the results. As one of the SEE-Impact research team observed in
her notes:
‘It is possible to see how [research with stakeholders rather than
stakeholder engagement] continues to gain insights for the devel-
opment of the tool. In fact it may gain more detailed feedback
through the observations of individuals as they use the tool.
However, is it likely to build ownership of the tool in the same
way as the planned face to face stakeholder engagement exer-
cises?’ exert from SEE-Impact researcher field notes
At this point, the dual goals of stakeholder engagement in
EQUIPT (improving the tool and promoting use of the tool) seemed
to uncouple and shift. While the importance of stakeholder views in
shaping the tool remained in the foreground, the opportunity to re-
cast stakeholder engagement as a research activity for academic pub-
lication purposes proved attractive to some of the team members. At
this stage in the process, the second goal of stakeholder engagement
(to build relationships and ownership of the tool in order to promote
use) was mainly supported by some of the country teams, who still
felt this was crucial for the success of the tool. In particular, the
Spanish and Hungarian team seemed to be more committed to a
more personalized approach to stakeholder engagement, as reflected
in the words of a Spanish EQUIPT researcher:
“The first sentence was: ‘This questionnaire is to test the users’.
Maybe if you are a stakeholder you will think: ‘okay, what are
they asking me, what will they ask me?’. If [the interviewers] are
stating that in the very first thing in the questionnaire; it makes
[the stakeholders] suspect that it will be an exam. (. . .) So, I told
[the Dutch questionnaire developers]: keep that in mind, that the
interview, it is not an exam. Don’t see it like an exam. But I think
the Hungarians said something related to that as well” Lucia,
EQUIPT researcher
A Hungarian EQUIPT member would later explain that some
country teams: ‘(. . .) may have a different perspective on [engage-
ment] and a different information need. For them the
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documentation, the screenshots, might be very useful for the re-
search purpose.’ [Vilmos, EQUIPT researcher]. When he was asked
to explain how this approach would affect the overall engagement
of stakeholders he said: ‘If you want to distinguish yourself, and if
you want to build a more personal relation to them - especially, if
you want them to later use the tool - I think a personal meeting
would have been a better option.’
The shift towards a more scientific stakeholder engagement ap-
proach was not the case for all the work presented in Budapest, and
the perceived needs of stakeholders were regularly mentioned by
members of the team throughout the meeting. The work packages
presented by non-academic collaborators continued to emphasize
the importance of bringing people together: The team looking at the
transferability of the tool to other European countries presented
their plans for engaging with stakeholders in a face-to-face event in
Zagreb to explore issues of transferability. Besides, the UK team was
looking to convene a meeting of stakeholders who had used the pre-
vious ROI tool to identify learning for the implementation of the
new EQUIPT tool.
3.2.4 Brussels—September 2016
The EQUIPT project was concluded with an end-of-project meeting
in Brussels. The meeting covered 3 days, of which one was dedicated
to discussion with the research advisory group, another day was
focussed on presenting the tool to external guests, and the final day
was an internal meeting for the research team. At the end of the first
day, the tool itself had yet to be presented:
‘Some researchers in the meeting seem to be rather distant from
the non-academic tobacco control practice. The entire meeting
and I have not seen the model itself yet, whilst all the technical
aspects have been exhibited. It feels a little like selling a vehicle,
but then only showing the engine bay and obfuscating the exter-
ior.’ exert from SEE-Impact researcher field notes
The second day was opened by a former Minister of Health from
Austria. Afterwards, EQUIPT team would continue to present three
themes: (1) stakeholder engagement in EQUIPT, (2) EQUIPT and
decision making and (3) transferability of the tool. The first theme
was meant to share lessons derived from the various stakeholder en-
gagement activities. A presentation from Ana, a senior EQUIPT re-
searcher, emphasized that stakeholder engagement ‘takes a lot of
effort, especially if you have to build a model from scratch’. They
would continue to explain that the team ‘also wanted to maintain
[their] scientific integrity’—which sometimes led to exclusion of
stakeholders or their inputs.
During lunch, one of the observers of the SEE-Impact study
asked a lead modeller whether the tool itself would be presented
during the meeting. The modeller explained that such a presentation
was not scheduled and that, given uncertainty over the stability of
the tool, they could risk disappointing the stakeholders. He also con-
fessed that they had not actually considered a live presentation.
After a short deliberation among the EQUIPT team, they decided to
showcase the tool shortly after lunch.
At the team meeting following the final stakeholder event in
Brussels, members of the team reflected on the misfit between the
style and content of the event (with a series of academic presenta-
tions from a podium) and what they felt on reflection the audience
might have appreciated (an opportunity for stakeholders to directly
engage with the new ROI tool). The team had spent sufficient time
discussing the importance of stakeholder involvement throughout
the project to see that the event they had organized was more suited
to an academic audience than to the assembled group of potential
users of the tool. One of the team commented that ‘I don’t think we
(the team and the audience) were speaking the same language’ she
talked about the lack of a ‘real connection’ with stakeholders.
Comparisons were drawn with a previous stakeholder event in
Zagreb (led by the Hungarian team) which had provided plenty of
opportunities for interactions between the team and stakeholders
and was considered by many in the team to have set a higher bar in
terms of expectations of stakeholder engagement in the project. One
of the co-applicants (Ana, theme lead) reflected on the potential ten-
sions for the team between close working with stakeholders and the
importance of maintaining academic integrity.
There was considerable variation within the EQUIPT team
regarding the importance of stakeholder engagement. While stake-
holder feedback was consistently welcomed, valued and responded
to by members of the team, there was less consensus about its wider
potential value in relation to use and impact. In some of the
EQUIPT countries, the stakeholder engagement was directly associ-
ated with an idea to increase the tool’s use. In these countries, the re-
sponsible EQUIPT team maintained friendly contact with actors
that could be seen as potential users of the tool. Other countries
adopted a more generic understanding of potential users, such as
‘decision makers’ or ‘researchers’.
Some EQUIPT research team members appeared to place greater
significance on stakeholder engagement than other team members.
They talked about the importance of more ‘hands on’ and ‘practical’
input from stakeholders and viewed the stakeholder events as being
too static and research focussed. In their language, they placed a
value on fully engaging and making a ‘real connection’ between
stakeholders and the EQUIPT team. This perspective aligned with
the underpinning theory of change which outlined a more bottom-
up approach to its stakeholder engagement, ‘working with people
who are going to be making decisions in the future (and with current
stakeholders) to work together to convince politicians’ [researcher
observation notes].
However, for some, this may have been to do with practical issues
such as awareness of time restraints around the project and the need
to deliver the tool on time. Some members of the team prioritized the
academic elements of the project (e.g. the completion of a PhD by a
team member and academic publications), often directly at the ex-
pense of stakeholder engagement activities. Furthermore, when this
tension came to a head at a meeting of the EQUIPT project team and
its advisors, the promise of turning stakeholder engagement activity
into research data and academic outputs gained support from the
partnership as a whole. The prospective of applying for follow on EU
Horizon 2020 funding potentially provided a further incentive to
focus on outputs. The ‘irresistible pull’ of academic norms proved too
strong to resist, despite a considerable interest and commitment to
stakeholder engagement in the programme.
Interview participant: I don’t know, um, the stakeholders have dif-
ferent ideas as well. Probably some say, then you know, then you
have, then you know, more difficult, then it is more difficult to de-
termine the direction of what you are going to investigate, I think.
Interviewer: Yes.
Interview participant: And maybe we think something, as a sci-
entist, is very important and then they say that it is absolutely not
important, and then if they have a very large part in the process,
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then you can no longer, then you can no longer do your own
thing.’ Peter, EQUIPT researcher
Here, Peter, one of EQUIPT project team reflects on some of the
difficulties that stakeholders’ feedback presented for the technical
tool development work and, to the threat to his academic autonomy
in stakeholders affecting his ability to ‘determine the direction’ of
his work. Ana reflected on how different stakeholder engagement
would have felt with the stakeholders sitting ‘at the table’ rather
than completing a survey.
Interview participant: Yes, well, I mean, what happened here [in
EQUIPT]: the interviewer asks the stakeholders something, the
interviewers summarize that, report it to the researchers, the
researchers say ‘yes we do’ or very often ‘we do not for those and
those reasons’, and then after a while we start asking the stake-
holders again. You know, and that was it.
Interviewer: Yes
Interview participant: Um, while I think if someone really sat at
the table where those decisions are made, it might have been
something else. [Ana, theme lead, EQUIPT]
4. Discussion
The collaborative work in the EQUIPT project was identified as a key
feature of the study design with pre-designated co-creation spaces
within the work programme—the so called ‘working space’ and
‘transfer space.’ Over the course of the study, however, the tool devel-
opment work and stakeholder engagement activities decoupled and
ceased to occupy a shared space. The impetus for the decoupling
seemed to come simultaneously from two directions and was facili-
tated by the organization of the activities in different engagement and
production work packages. Despite the plans for co-creation in the
working space of the programme, the technical work on the model-
ling for the new tool increasingly took place in parallel to what, by
then, was more conventional consultation. Modelling and tool devel-
opment increasingly occurred in the sort of ‘secluded’ space described
by Callon et al. (2009), where there is a technical job of work to be
done and outside influence can often be characterized as uncertain,
unpredictable and lacking timeliness. The real-world challenges pre-
sented by delays in commencing the study and the time required to set
up face-to-face stakeholder engagement had significant implications
for the modellers working to a tight timetable to develop new versions
of the tool for prototype testing in the different countries.
In the course of the project, most of the planned ‘co-production’
activities subtly transformed to consultation, and eventually, for some
of the activity, to research participation where stakeholders com-
pleted surveys generating data that was subject to detailed analysis
and written up for publication in peer-reviewed journals. A first step,
responding to time pressures in project delivery, involved replacing
the planned face-to-face stakeholder workshops with online one-to-
one consultations, where developments in technology made it possible
to make both audio and visual recordings of stakeholders testing the
prototype tools. While this process generated detailed data on the dif-
ferent elements of the prototype tool from stakeholders, it did not do
so in close collaboration with the modellers.
While the project team seemed to form a successful interdiscip-
linary collaboration of academics (Roelofs et al. 2019), the eventual
collaborative research practice did not result in similar opportunities
for building engagement with and ownership of the tool amongst a
wider group of stakeholders across the different countries. One of
the EQUIPT studies shows that Hungarian and Spanish stakeholders
‘wanted to use the tool basically as soon as possible’ whereas ‘Dutch
and German interviewees were least interested’ (Vokó et al. 2016).
A previous SEE-Impact study has described how this difference
relates to the more personalized approach by the Hungarian and
Spanish project teams, where the notion of ‘stakeholders’ was com-
monly translated into concrete actors and positions (Borst et al.
2019).
The study also surfaced a more fundamental challenge to close
working with stakeholders in knowledge production and use. Mary
Henkel’s work (2005) on academic identity and autonomy in chang-
ing policy environments explored how academics respond to the
promise and challenges of working closely with stakeholders outside
of the academy. It is also echoed in the findings of Timotijevic et al.
(2013) study of stakeholder involvement in scientific decision mak-
ing where they observed stakeholder engagement being used to con-
firm the authority of science over the facts as opposed to any
evidence of a reframing of scientific practice. As Morgan et al.
(2011) observe, existing university policies and practices support
particular models of knowledge production. As a consequence,
more applied, collaborative approaches to research can end up left
to one side as the dominant model of academic knowledge produc-
tion (driven by the science and not primarily concerned with applic-
ability and use of research findings) asserts its authority.
The value of stakeholder engagement was articulated clearly and
consistently by the EQUIPT project team throughout. This reflects
what Goffman (1963) would characterize as a shared performance
front of stage. Furthermore, the substantive content of the work
aligned with their values in terms of promoting the importance of
supporting a more evidence-based approach to making return on in-
vestment decisions in tobacco control. Several members of the
EQUIPT team highlighted their prior positive experience of stake-
holder engagement in developing the UK ROI tool. Where this com-
mitment started to unravel was ‘backstage’ where the more intensive
engagement and co-production elements started to ‘rub up against’
the priorities and ways of working of academia. Kislov et al. (2017)
and Lozeau et al. (2002) note the impact of similar ‘compatibility
gaps’ between new practices and the cultural, structural and political
characteristics of the system in their studies of service improvement.
While participants in the study had fully internalized the import-
ance of academic writing and grant writing as an integral part of
their role, stakeholder engagement, and in particular the planned
co-production activities remained vulnerable to internal and exter-
nal pressures. While there were many differences within the team,
there was concordance on the importance of publications. Despite
the substantial stakeholder engagement built into the study through-
out, the importance of academic publications ‘trumped’ stakeholder
engagement at every turn. There was an exuberant moment when
the team as a whole saw the opportunity to publish the outcomes of
their stakeholder engagement work in a peer-reviewed journal.
The vulnerability of working with stakeholders has particular
implications for the currently promotion of co-production of know-
ledge in health services research. Our tendency to see involving
stakeholders as a benign ‘add on’ that will enhance the quality of
our research misses the underlying epistemological challenge pre-
sented by stakeholder engagement and in particular by co-produc-
tion as described by Jasanoff (2004):
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‘Co-production can therefore be seen as a critique of the realist
ideology that persistently separates the domains of nature, facts,
objectivity, reason and policy from those of culture, values, sub-
jectivity, emotion and politics.’ (Jasanoff 2004: 3)
For co-production in particular, the approach is not merely a set
of activities, but a fundamental and epistemologically different way
of working from conventional knowledge production (Ostrom
1996). There is a long tradition in science and technology studies in
surfacing the challenges of stakeholder engagement and co-produc-
tion (Jasanoff 2004; Callon et al. 2009). However, much of the de-
bate in the health services research continues to focus on limited
uptake of research in policy and practice settings (Ferlie et al. 2000;
Currie and Suhomlinova 2006). This article provides a timely re-
minder that the epistemological, institutional and personal chal-
lenges that come from within the academic sector also need to be
surfaced and explored to support the future role of social science re-
search in health policy and practice.
We do not to argue against the potential contribution of stake-
holder engagement and co-production, but show how even good
intentions and well-planned engagement activities can be diverted
within the existing research funding and research production sys-
tems where non-research stakeholders remain at the margins and
can even be seen as a threat to academic idendity and autonomy.
This study is not without limitations. Not all of the research
Equipt team were willing to participate in interviews and so in some
instances, it was not possible to explore further issues arising from
the observations. A further limitation is that we were looking at one
type of technical research output (a return-on-investment tool) and
the conclusions may not apply in the same way to other processes of
knowledge production and types of research product. Finally, while
there was clearly a value to taking a prospective approach to study-
ing stakeholder engagement, this brought particular challenges in
terms of the fieldwork. Significant flexibility was required and nu-
merous changes had to be made to the study design to reflect
changes in the EQUIPT study and the proposed stakeholder engage-
ment activities.
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